Ifinatamab Biosimilar - Research Grade

Human

B7-H3

5mg/ml

Human IgG1 Kappa

CHO Cells

Products are for research use only. Not for use in diagnostic or therapeutic procedures.

This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.

Functional Assays

This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.

Sterile, preservative-free, solution in PBS. BSA and Azide free.

This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.

Detects B7-H3

Blue ice

B7-H3 (CD276) is an immune-modulatory molecule broadly over-expressed on solid tumours and a prominent target in cancer-targeting research. Supplied as an unconjugated, non-therapeutic analog of ifinatamab, this recombinant anti-human B7-H3 monoclonal is for research use only (RUO). It is manufactured to in vivo standards with low endotoxin and produced in scalable milligram (mg) to gram (g) quantities for bulk and high-throughput laboratories. Researchers use it in functional assays, tumour-binding and internalisation studies, ADC-development workflows, reproducible controls, and in vivo solid-tumour models, relying on its lot-to-lot consistency for large, heavy-usage experimental campaigns.

MABX-9001a;B7H3, B7-H3, B7-related protein 2, B7RP2, B7RP-2, B7 homolog 3, B7 homologue 3,CD276

Q5ZPR3

ICH3002

https://www.imgt.org/mAb-DB/